Format

Send to

Choose Destination
J Clin Invest. 2013 May;123(5):1911-8. doi: 10.1172/JCI66024. Epub 2013 May 1.

Cancer stem cells in the development of liver cancer.

Author information

1
Department of General Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan. taroy@m-kanazawa.jp

Abstract

Liver cancer is an aggressive disease with a poor outcome. Several hepatic stem/progenitor markers are useful for isolating a subset of liver cells with stem cell features, known as cancer stem cells (CSCs). These cells are responsible for tumor relapse, metastasis, and chemoresistance. Liver CSCs dictate a hierarchical organization that is shared in both organogenesis and tumorigenesis. An increased understanding of the molecular signaling events that regulate cellular hierarchy and stemness, and success in defining key CSC-specific genes, have opened up new avenues to accelerate the development of novel diagnostic and treatment strategies. This Review highlights recent advances in understanding the pathogenesis of liver CSCs and discusses unanswered questions about the concept of liver CSCs.

PMID:
23635789
PMCID:
PMC3635728
DOI:
10.1172/JCI66024
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center